ADMS – Adamas Pharmaceuticals, Inc. –

  • Quotes
  • Charts

News & Analysis for ADMS

ADAMAS PHARMACEUTICALS, INC. (NASDAQ:ADMS) Files An 8-K Other Events

ME Staff 8-k - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Hold rating reiterated by Needham...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Northland...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) gets downgraded to Underperform by Bank of...

ME Staff - 0

ADAMAS PHARMACEUTICALS, INC. (NASDAQ:ADMS) Files An 8-K Departure of Directors or...

ME Staff 8-k - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Evercore...

ME Staff - 0

ADAMAS PHARMACEUTICALS, INC. (NASDAQ:ADMS) Files An 8-K Submission of Matters to...

ME Staff 8-k - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Northland...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) gets downgraded to Hold by Needham &...

ME Staff - 0

ADAMAS PHARMACEUTICALS,INC. (NASDAQ:ADMS) Files An 8-K Results of Operations and Financial...

ME Staff 8-k - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) price target set to $40.00 by HC...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by HC...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) gets downgraded to Neutral by Bank of...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) price target set to $45.00 by HC...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) price target set to $45.00 by HC...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by HC...

ME Staff - 0

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) has coverage initiated with a Buy rating...

ME Staff - 0

Analyst Activity – Mizuho Reiterates Buy on NASDAQ:ADMS – Adamas Pharmaceuticals...

ME Staff - 0
Load more